Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$0.6 - $1.53 $234 - $596
390 Added 0.52%
74,996 $44,000
Q2 2023

Aug 11, 2023

BUY
$1.05 - $1.63 $6,048 - $9,388
5,760 Added 8.37%
74,606 $84,000
Q4 2022

Feb 07, 2023

BUY
$1.71 - $3.61 $1,060 - $2,238
620 Added 0.91%
68,846 $128,000
Q2 2022

Aug 05, 2022

BUY
$2.13 - $9.01 $21 - $90
10 Added 0.01%
68,226 $166,000
Q4 2021

Feb 08, 2022

BUY
$14.7 - $28.67 $44,643 - $87,070
3,037 Added 4.66%
68,216 $1.04 Million
Q3 2021

Nov 08, 2021

BUY
$24.31 - $33.6 $15,315 - $21,168
630 Added 0.98%
65,179 $1.85 Million
Q2 2021

Aug 10, 2021

BUY
$26.09 - $40.4 $518,147 - $802,344
19,860 Added 44.44%
64,549 $2.18 Million
Q1 2021

May 10, 2021

SELL
$33.06 - $56.93 $104,800 - $180,468
-3,170 Reduced 6.62%
44,689 $1.71 Million
Q4 2020

Feb 08, 2021

SELL
$39.09 - $57.4 $24,235 - $35,588
-620 Reduced 1.28%
47,859 $2 Million
Q3 2020

Nov 09, 2020

BUY
$28.43 - $44.67 $25,871 - $40,649
910 Added 1.91%
48,479 $2.1 Million
Q2 2020

Aug 07, 2020

BUY
$11.71 - $30.29 $169,268 - $437,841
14,455 Added 43.65%
47,569 $1.44 Million
Q3 2019

Nov 07, 2019

BUY
$18.85 - $27.5 $3,600 - $5,252
191 Added 0.58%
33,114 $638,000
Q2 2019

Aug 05, 2019

BUY
$17.37 - $26.27 $244,917 - $370,407
14,100 Added 74.91%
32,923 $774,000
Q1 2019

May 03, 2019

BUY
$10.65 - $25.75 $2,662 - $6,437
250 Added 1.35%
18,823 $441,000
Q4 2018

Feb 01, 2019

BUY
$9.26 - $16.38 $22,964 - $40,622
2,480 Added 15.41%
18,573 $205,000
Q3 2018

Oct 31, 2018

BUY
$7.54 - $18.31 $7,464 - $18,126
990 Added 6.55%
16,093 $269,000
Q2 2018

Aug 06, 2018

BUY
$4.87 - $8.42 $4,236 - $7,325
870 Added 6.11%
15,103 $111,000
Q3 2017

Oct 31, 2017

BUY
$8.89 - $10.4 $126,531 - $148,023
14,233
14,233 $133,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.